With reference to CDSL’s Operating Instructions for Issuers / RTAs, which states that the Issuer / RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, Panacea Biotec has informed that no share has been dematerialized during the month of July 2026. The company has confirmed that the total number of shares dematerialized as on July 31, 2026, were as under: NSDL 5,26,65,454 CDSL 84,40,072 Total 6,11,05,526 A copy of the certificate obtained from the Company’s RTA - Skyline Financial Services, regarding shares dematerialized as on July 31, 2026, is also enclosed as Annexure -1.
The above information is a part of company’s filings submitted to BSE.
